Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aniline SCHEMBL22169152 | 0.91 | TSHR (0.48) | ALOX15CYP3A4CASP1CASP7SMN1; SMN2 | |
| SCHEMBL1068978 | 0.90 | NOS1 (0.41) | ALOX15CYP3A4CASP1CASP7SMN1; SMN2 | |
| SCHEMBL1067058 | 0.90 | KDM4E (0.44) | ALOX15CYP3A4CASP1CASP7SMN1; SMN2 | |
| SCHEMBL8932238 | 0.89 | MEN1 (0.47) | ALOX15CYP3A4CASP1CASP7SMN1; SMN2 | |
| SCHEMBL8786474 | 0.88 | KDM4E (0.47) | ALOX15CYP3A4CASP1CASP7SMN1; SMN2 | |
| SCHEMBL570948 | 0.88 | KDM4E (0.47) | ALOX15CYP3A4CASP1CASP7SMN1; SMN2 | |
| SCHEMBL4849477 | 0.88 | KDM4E (0.47) | ALOX15CYP3A4CASP1CASP7SMN1; SMN2 | |
| SCHEMBL9377442 | 0.88 | KDM4E (0.47) | ALOX15CYP3A4CASP1CASP7SMN1; SMN2 | |
| SCHEMBL3553262 | 0.84 | HTR2C (0.60) | HTR2C | |
| SCHEMBL29922358 | 0.84 | HTR2C (0.60) | HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117143007-A | Tetrahydrocarbazole derivative and photocatalytic synthesis method thereof | 陕西科技大学 | 2023-12-01 | — | — | CN | claimed |
| CN-114057623-A | N-naphthyl indole derivative and synthetic method thereof | 湖南第一师范学院 | 2022-02-18 | — | — | CN | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| EP-0577945-B1 | Herbicide intermediate o-nitrophenyl cyclopropyl ketone and a method for the preparation thereof | AMERICAN CYANAMID CO (US) | 1996-08-14 | — | — | EP | claimed |
| EP-0030514-B1 | ANILINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM FOR REGULATING PLANT-GROWTH | RHONE-POULENC AGROCHIMIE (FR) | 1983-08-17 | — | — | EP | claimed |
| EP-0030514-A1 | Aniline derivatives, process for their preparation and compositions containing them for regulating plant-growth | RHONE-POULENC AGROCHIMIE (FR) | 1981-06-17 | — | — | EP | claimed |
| JP-11035531-A | — | — | None | — | — | JP | disclosed |
| JP-62030772-A | — | — | None | — | — | JP | disclosed |
| EP-4735114-A1 | SUBSTITUTED THIENO [3,2-B]PYRIDINES AS INHIBITORS OF PROTEIN KINASES | Masarykova Univerzita (CZ) | 2026-05-06 | — | — | EP | disclosed |
| US-12503467-B2 | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors | IDEAYA BIOSCIENCES, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250381187-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC. (US) | 2025-12-18 | — | — | US | disclosed |
| US-12479845-B2 | Imidazopyridine derivative compounds and use of same | HANMI PHARM. CO., LTD. (KR) | 2025-11-25 | — | — | US | disclosed |
| US-12440491-B2 | KRAS G12C inhibitors and methods of using the same | AMGEN INC. (US) | 2025-10-14 | — | — | US | disclosed |
| EP-0711757-A1 | 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy -pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists | F. Hoffmann-La Roche AG (CH) | 1996-05-15 | — | — | EP | disclosed |
| WO-1996007657-A1 | PYRIMIDO[5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM | DR. KARL THOMAE GMBH (DE) | 1996-03-14 | — | — | WO | disclosed |
| JP-S6230772-A | CYCLOPROPYLANILINE DERIVATIVE | TOKYO TANABE CO LTD | 1987-02-09 | — | — | JP | disclosed |
| EP-0149237-A2 | 1,4-Dihydropyrazines, process for their preparation and their use in medicines | BAYER AG (DE) | 1985-07-24 | — | — | EP | disclosed |
| EP-0030514-B1 | ANILINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM FOR REGULATING PLANT-GROWTH | RHONE-POULENC AGROCHIMIE (FR) | 1983-08-17 | — | — | EP | disclosed |
| EP-0030514-A1 | Aniline derivatives, process for their preparation and compositions containing them for regulating plant-growth | RHONE-POULENC AGROCHIMIE (FR) | 1981-06-17 | — | — | EP | disclosed |
| EP-0030514-A1 | Aniline derivatives, process for their preparation and compositions containing them for regulating plant-growth | RHONE-POULENC AGROCHIMIE (FR) | 1981-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250381187-A1 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | KRAS, NRAS, HRAS | ALOX15 3170/4885CYP3A4 4739/4885CASP1 3637/4885 |
| US-12440491-B2 | KRAS G12C inhibitors and methods of using the same | KRAS, NRAS, HRAS | ALOX15 3170/4885CYP3A4 4739/4885CASP1 3637/4885 |
| US-12479845-B2 | Imidazopyridine derivative compounds and use of same | KDM1A, KDM1B, KDM2A | ALOX15 1758/4885CYP3A4 843/4885CASP1 1492/4885 |
| US-12503467-B2 | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors | MAT2B, MAT2A, MAT1A | ALOX15 4067/4885CYP3A4 3573/4885CASP1 4328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.